| 32645325 |
The Global Phosphorylation Landscape of SARS-CoV-2 Infection
Bouhaddou, M,
Memon, D,
Meyer, B,
White, KM,
Rezelj, VV,
Correa Marrero, M,
Polacco, BJ,
Melnyk, JE,
Ulferts, S,
Kaake, RM,
Batra, J,
Richards, AL,
Stevenson, E,
Gordon, DE,
Rojc, A,
Obernier, K,
Fabius, JM,
Soucheray, M,
Miorin, L,
Moreno, E,
Koh, C,
Tran, QD,
Hardy, A,
Robinot, R,
Vallet, T,
Nilsson-Payant, BE,
Hernandez-Armenta, C,
Dunham, A,
Weigang, S,
Knerr, J,
Modak, M,
Quintero, D,
Zhou, Y,
Dugourd, A,
Valdeolivas, A,
Patil, T,
Li, Q,
Hüttenhain, R,
Cakir, M,
Muralidharan, M,
Kim, M,
Jang, G,
Tutuncuoglu, B,
Hiatt, J,
Guo, JZ,
Xu, J,
Bouhaddou, S,
Mathy, CJP,
Gaulton, A,
Manners, EJ,
Félix, E,
Shi, Y,
Goff, M,
Lim, JK,
McBride, T,
O'Neal, MC,
Cai, Y,
Chang, JCJ,
Broadhurst, DJ,
Klippsten, S,
de Wit, E,
Leach, AR,
Kortemme, T,
Shoichet, B,
Ott, M,
Saez-Rodriguez, J,
tenOever, BR,
Mullins, RD,
Fischer, ER,
Kochs, G,
Grosse, R,
García-Sastre, A,
Vignuzzi, M,
Johnson, JR,
Shokat, KM,
Swaney, DL,
Beltrao, P,
Krogan, NJ
|
Cell |
2020 |
| 32817937 |
The FDA-approved drug Alectinib compromises SARS-CoV-2 nucleocapsid phosphorylation and inhibits viral infection in vitro
Yaron, TM,
Heaton, BE,
Levy, TM,
Johnson, JL,
Jordan, TX,
Cohen, BM,
Kerelsky, A,
Lin, TY,
Liberatore, KM,
Bulaon, DK,
Kastenhuber, ER,
Mercadante, MN,
Shobana-Ganesh, K,
He, L,
Schwartz, RE,
Chen, SB,
Weinstein, H,
Elemento, O,
Piskounova, E,
Nilsson-Payant, BE,
Lee, G,
Trimarco, JD,
Burke, KN,
Hamele, CE,
Chaparian, RR,
Harding, AT,
Tata, A,
Zhu, X,
Tata, PR,
Smith, CM,
Possemato, AP,
Tkachev, SL,
Hornbeck, PV,
Beausoleil, SA,
Anand, SK,
Aguet, F,
Getz, G,
Davidson, AD,
Heesom, K,
Kavanagh-Williamson, M,
Matthews, D,
tenOever, BR,
Cantley, LC,
Blenis, J,
Heaton, NS
|
bioRxiv |
2020 |